A spotlight on the management of complications associated with myeloproliferative neoplasms a clinician's perspective

Research output: Contribution to journalArticle

251 Downloads (Pure)

Abstract

INTRODUCTION:

Myeloproliferative neoplasms (MPNs) are associated with a variety of symptoms and signs which cause major morbidity for the patients. The disorders are associated with increased incidence of thromboembolic and hemorrhagic events which can lead to complications and shortened life expectancy. Areas covered: Using systematic literature review and expert clinical and research experience the authors discuss strategies for the management of symptoms and signs including pruritus, fatigue, splenomegaly, and cytopenia. Cytoreduction including treatments to inhibit the JAK/STAT pathway are considered. Pathogenesis and prevention and treatment of thrombotic and hemorrhagic events and their management is addressed and the suggested management of the special situations such as surgery and pregnancy are discussed. Expert commentary: Management of disease has traditionally focused on symptom treatment and complication prevention but the discovery of driver mutations has led to treatments aiming to eliminate the clone, which should be the ultimate goal of therapy. A future challenge is to develop safe and effective MPN therapy and to personalize therapy.

Original languageEnglish
Pages (from-to)25-35
JournalEXPERT REVIEW OF HEMATOLOGY
Volume11
Issue number1
Early online date29 Nov 2017
DOIs
Publication statusPublished - 02 Dec 2017

Keywords

  • Journal Article

Fingerprint Dive into the research topics of 'A spotlight on the management of complications associated with myeloproliferative neoplasms a clinician's perspective'. Together they form a unique fingerprint.

  • Cite this